Accueil   Diary - News   All news ERYTECH Wins Deloitte Technology Fast 50 Award

ERYTECH Wins Deloitte Technology Fast 50 Award

ERYTECH Pharma, the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other malignancies with unmet medical needs, announced today that it received Deloitte Technology Fast 50 award in the “Promising Biotech” category for France’s Grand Rhone-Alpes region.


Read the press release

 

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree